Skip to main content
Log in

Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model

  • Genomics, transcriptomics, proteomics
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Colorectal cancer is a public health problem, with dysbiosis being one of the risk factors due to its role in intestinal inflammation. Probiotics and synbiotics have been used in order to restore the microbiota balance and to prevent colorectal carcinogenesis. We aimed to investigate the effects of the probiotic VSL#3® alone or in combination with a yacon-based prebiotic concentrate on the microbiota modulation and its influence on colorectal carcinogenesis in an animal model. C57BL/6J mice were divided into three groups: control (control diet), probiotic (control diet + VSL#3®), and synbiotic (yacon diet + VSL#3®). The diets were provided for 13 weeks and, from the third one, all animals were subjected to induction of colorectal cancer precursor lesions. Stool samples were collected to evaluate organic acids, feces pH, β-glucuronidase activity, and microbiota composition. The colon was used to count pre-neoplastic lesions and to determine the cytokines. The microbiota composition was influenced by the use of probiotic and synbiotic. Modifications were also observed in the abundance of bacterial genera with respect to the control group, which confirms the interference of carcinogenesis in the microbiota. Pre-neoplastic lesions were reduced by the use of the synbiotic, but not with the probiotic. The protection provided by the synbiotic can be attributed to the modulation of the intestinal inflammatory response, to the inhibition of a pro-carcinogenic enzyme, and to the production of organic acids. The modulation of the composition and activity of the microbiota contributed to beneficial changes in the intestinal microenvironment, which led to a reduction in carcinogenesis.

Key points

• Synbiotic reduces the incidence of colorectal cancer precursor lesions.

• Synbiotic modulates the composition and activity of intestinal microbiota.

• Synbiotic increases the abundance of butyrate-producing bacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  • Anuradha S, Rajeshwari K (2005) Probiotics in health and disease. J Ind Acad Clin Med 6:67–72

    Google Scholar 

  • Armaghany T, Wilson JD, Chu Q, Mills G (2012) Genetic alterations in colorectal cancer. Gastrointest Cancer Res 5:19–27

    PubMed  PubMed Central  Google Scholar 

  • Arthur J, Jobin C (2011) The struggle within: microbial influences on colorectalcancer. Inflamm Bowel Dis 17:396–409

    PubMed  Google Scholar 

  • Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C (2013) VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep 3:2868. https://doi.org/10.1038/srep02868

  • Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS (2008) Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 23(8 Pt 1):1298–1303. https://doi.org/10.1111/j.1440-1746.2008.05490.x

    Article  CAS  PubMed  Google Scholar 

  • Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Hontecillas R (2012) Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 7:e34676

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bedani R, Pauly-Silveira ND, Cano VSP, Valentini SR, Valdez GF, Rossi EA (2011) Effect of ingestion of soy yogurt on intestinal parameters of rats fed on a beef-based animal diet. Braz J Microbiol 42(3):1238–1247. https://doi.org/10.1590/S1517-83822011000300050

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bird RP, Good CK (2000) The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112-113:395–402. https://doi.org/10.1016/s0378-4274(99)00261-1

    Article  CAS  PubMed  Google Scholar 

  • Cabal-Hierro L, O'Dwyer PJ (2017) TNF signaling through RIP1 kinase enhances SN38-induced death in colon adenocarcinoma. Mol Cancer Res 15(4). https://doi.org/10.1158/1541-7786.MCR-16-0329

  • Calderwood AH, Lasser KE, Roy HK (2016) Colon adenoma features and their impact on risk of future advanced adenomas and colorectal cancer. World J Gastrointest Oncol 15:826–834. https://doi.org/10.4251/wjgo.v8.i12.826

    Article  Google Scholar 

  • Chandel D, Sharma M, Chawla V, Sachdeva N, Shukla G (2019) Isolation, characterization and identification of antigenotoxic and anticancerous indigenous probiotics and their prophylactic potential in experimental colon carcinogenesis. Sci Rep 9:14769. https://doi.org/10.1038/s41598-019-51361-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chang JH, Shim YY, Cha SK, Reaney MJT, Chee KM (2012) Effect of Lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon. J Med Microbiol 61(pt 3):361–368

    CAS  PubMed  Google Scholar 

  • Chen L, Wang W, Zhou R, Ng SC, Li J, Huang M, Zhou F, Wang X, Shen B, A Kamm M, Wu K, Xia B (2014) Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease. Md Med J 93(8):e51

    CAS  Google Scholar 

  • Chen D, Jin D, Huang S, Wu J, Xu M, Liu T, Dong W, Liu X, Wang S, Zhong W, Liu Y, Jiang R, Piao M, Wang B, Cao H (2020) Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett 469:456–467. https://doi.org/10.1016/j.canlet.2019.11.019

    Article  CAS  PubMed  Google Scholar 

  • Cheng X, Xu X, Chen D, Zhao F, Wang W (2019) Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer. Biomed Pharmacother 110:473–481. https://doi.org/10.1016/j.biopha.2018.11.082

    Article  CAS  PubMed  Google Scholar 

  • Chung EJ, Do EJ, Kim SY, Cho EA, Kim DH, Pak S, Hwang SW, Lee HJ, Byeon JS, Ye BD, Yang DH, Park SH, Yang SK, Kim JH, Myung SJ (2017) Combination of metformin and VSL#3 additively suppresses western-style diet induced colon cancer in mice. Eur J Pharmacol 794:1–7

    CAS  PubMed  Google Scholar 

  • Corthésy B, Gaskins HR, Mercenier A (2007) Cross-talk between probiotic bacteria and the host immune system. J Nutr 137:781–790

    Google Scholar 

  • Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, Sauvanet P, Darcha C, Déchelotte P, Bonnet M, Pezet D, Wodrich H, Darfeuille-Michaud A, Bonnet R (2014) Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 63:1932–1942. https://doi.org/10.1136/gutjnl-2013-305257

    Article  CAS  PubMed  Google Scholar 

  • Cruz BCS, Sarandy MM, Messias AC, Gonçalves RV, Ferreira CLLF, Peluzio MCG (2020) Preclinical and clinical relevance of probiotics and synbiotics in colorectal carcinogenesis: a systematic review. Nutr Rev. https://doi.org/10.1093/nutrit/nuz087

  • Dai C, Zheng CQ, Meng FJ, Zhou Z, Sang LX, Jiang M (2013) VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-kappaB pathway in rat model of DSS-induced colitis. Mol Cell Biochem 374:1–11

    CAS  PubMed  Google Scholar 

  • De Freitas LS, Lopes DC, De Freitas AF, Carneiro JDC, Corassa A, Pena SDM, Costa LF (2006) Effects of feeding organic acids for piglets from 21 to 49 days old. Rev Bras Zootec 35:1711–1719. https://doi.org/10.1590/S1516-35982006000600019

    Article  Google Scholar 

  • de Moreno de LeBlanc A, Perdigon G (2005) Reduction of β-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell 29:15–24

    PubMed  Google Scholar 

  • De Nadai Marcon L, Moraes LFS, Cruz BCS, Teixeira MDO, Bruno TCV, Ribeiro IE, Messias AC, Ferreira CLLF, Oliveira LL, Peluzio MCG (2019) Yacon (Smallanthus sonchifolius)-based product increases fecal short-chain fatty acids and enhances regulatory T cells by downregulating RORγt in the colon of BALB/c mice. J Funct Foods 55:333–342

    Google Scholar 

  • De Preter V, Raemen H, Cloetens L, Houben E, Rutgeerts P, Verbeke K (2008) Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. Eur J Clin Nutr 62(2):225–231

    PubMed  Google Scholar 

  • De Preter V, Hamer HM, Windey K, Verbeke K (2011) The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? Mol Nutr Food Res 55:4657

    Google Scholar 

  • Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D (2008) Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10:37–54

    CAS  PubMed  Google Scholar 

  • Delgado GT, Thomé R, Gabriel DL, Tamashiro WM, Pastore GM (2012) Yacon (Smallanthus sonchifolius)-derived fructooligosaccharides improves the immune parameters in the mouse. Nutr Res 32:884–892. https://doi.org/10.1016/j.nutres.2012.09.012

    Article  CAS  PubMed  Google Scholar 

  • Dominici L, Villarini M, Trotta F, Federici E, Cenci G, Moretti M (2014) Protective effects of probiotic Lactobacillus rhamnosus IMC501 in mice treated with PhIP. J Microbiol Biotechnol 24:371–378

    PubMed  Google Scholar 

  • Engstrom A, Erlandsson A, Delbro D, Wijkander J (2014) Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2. Int J Oncol 44:385–392

    PubMed  Google Scholar 

  • Farrokhi AS, Mohammadlou M, Abdollahi M, Eslami M, Yousefi B (2019) Histone deacetylase modifications by probiotics in colorectal cancer. J Gastrointest Canc. https://doi.org/10.1007/s12029-019-00338-2

  • Fouad YA, Aanei C (2017) Revisiting the hallmarks of cancer. Am J Cancer Res 7(5):1016–1036 www.ajcr.us/ISSN:2156-6976/ajcr0053932

    CAS  PubMed  PubMed Central  Google Scholar 

  • Frank C, Sundquist J, Yu H, Hemminki A, Hemminki K (2017) Concordant and discordant familial cancer: familial risks, proportions and population impact. Int J Cancer 140:1510–1516

    CAS  PubMed  Google Scholar 

  • Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M (2016) Gut microbiota imbalance and colorectal cancer. World J Gastroenterol 22:501–518. https://doi.org/10.3748/wjg.v22.i2.501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gavresea F, Vagianos C, Korontzi M, Sotiropoulou G, Dadioti P, Triantafillidis JK, Papalois AE (2018) Beneficial effect of synbiotics on experimental colon cancer in rats. Turk J Gastroenterol 29:494–501

    PubMed  Google Scholar 

  • Gomides AFF, de Paula SO, Gonçalves RV, de Oliveira LL, Ferreira CL de LF, Comastri DF, Peluzio MCG (2014) Prebiotics prevent the appearance of aberrant crypt foci (ACF) in the colon of BALB/c mice for increasing the gene expression of p16 protein. Nutr Hosp 30:883–890

    PubMed  Google Scholar 

  • Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S, Woster PM, Sears CL, Casero RA (2011) Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci 108:15354–15359. https://doi.org/10.1073/pnas.1010203108

    Article  PubMed  PubMed Central  Google Scholar 

  • Grancieri M, Costa NMB, Vaz Tostes MDG, de Oliveira DS, Nunes LDC, Marcon LDN, Viana ML (2017) Yacon flour (Smallanthus sonchifolius) attenuates intestinal morbidity in rats with colon cancer. J Funct Foods 37. https://doi.org/10.1016/j.jff.2017.08.039

  • Hammer Ø, Harper DAT, Ryan PD (2001) PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontol Electron 4(1):9 http://palaeo-electronica.org/2001_1/past/issue1_01.htm

    Google Scholar 

  • Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70

    CAS  PubMed  Google Scholar 

  • Hatakka K, Holma R, El-Nezami H, Suomalainen T, Kuisma M, Saxelin M, Poussa T, Mykkänen H, Korpela R (2008) The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity inhuman colon. Int J Food Microbiol 128:406–410

    CAS  PubMed  Google Scholar 

  • Hijova E, Szabadosova V, Strojny L, Bomba A (2014) Changes chemopreventive markers in colorectal cancer development after inulin supplementation. Bratisl Lek Listy 115(2):76–79. https://doi.org/10.4149/BLL_2014_016

    Article  CAS  PubMed  Google Scholar 

  • Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514

    PubMed  Google Scholar 

  • Hoyer KK, Dooms H, Barron L, Abbas AK (2008) Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 226:19–28. https://doi.org/10.1111/j.1600-065X.2008.00697.x

    Article  CAS  PubMed  Google Scholar 

  • Igarashi M, Nakae H, Matsuoka T, Takahashi S, Hisada T, Tomita J, Koga Y (2017) Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ Open Gastroenterol 1:e000144. https://doi.org/10.1136/bmjgast-2017-000144

    Article  Google Scholar 

  • International Agency for Research Cancer (IARC) (2019) Cancer today. https://gco.iarc.fr/today/. Acess: March 16, 2020

  • Islam A, Gallaher DD (2015) Wheat type (class) influences development and regression of colon cancer risk markers in rats. Nutr Cancer 67:1285–1294

    CAS  Google Scholar 

  • Jacouton E, Michel ML, Torres-Maravilla E, Chain F, Langella P, Bermúdez-Humarán LG (2019) Elucidating the immune-related mechanisms by which probiotic strain Lactobacillus casei BL23 displays anti-tumoral properties. Front Microbiol 9:3281. https://doi.org/10.3389/fmicb.2018.03281

    Article  PubMed  PubMed Central  Google Scholar 

  • Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, Zhang D, Su Z, Fang Z, Lan Z, Li J, Xiao L, Li J, Li R, Li X, Li F, Ren H, Huang Y, Peng Y, Li G, Wen B, Dong B, Chen JY, Geng QS, Zhang ZW, Yang H, Wang J, Wang J, Zhang X, Madsen L, Brix S, Ning G, Xu X, Liu X, Hou Y, Jia H, He K, Kristiansen K (2017) The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 8:845

    PubMed  PubMed Central  Google Scholar 

  • Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, Berry DA (2013) Meta-analyses of colorectal cancer risk factors. Cancer Causes Control 24:1207–1222

    PubMed  PubMed Central  Google Scholar 

  • Karnoub AE, Weinberg RA (2007) Chemokine networks and breast cancer metastasis. Breast Dis 26:75–85

    Google Scholar 

  • Kearney SM, Gibbons SM (2018) Designing synbiotics for improved human health. Microb Biotechnol 11(1):141–144. https://doi.org/10.1111/1751-7915.12885

    Article  PubMed  Google Scholar 

  • Kim S, Keku TO, Martin C, Galanko J, Woosley JT, Schroeder JC, Satia JA, Halabi S, Sandler RS (2008) Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 68:323–328

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kumar M, Nagpal R, Verma V, Kumar A, Kaur N, Hemalatha R, Gautam SK, Singh S (2012) Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev 71:23–34

    PubMed  Google Scholar 

  • Le Blay G, Michel C, Blottière HM, Cherbut C (1999) Prolonged intake of fructooligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats. J Nutr 129(12):2231–2235. https://doi.org/10.1093/jn/129.12.2231

    Article  PubMed  Google Scholar 

  • Lee HA, Kim H, Lee KW, Park KY (2015) Dead nano-sized Lactobacillus plantarum inhibits azoxymethane/dextran sulfate sodium-induced colon cancer in Balb/c mice. J Med Food 18:1400–1405

    CAS  PubMed  Google Scholar 

  • Lee HL, Park MH, Song JK, Jung YY, Kim Y, Kim KB, Hwang DY, Yoon do Y, Song MJ, Han SB, Hong JT (2016) Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models. Oncotarget 7(17):23425–23438

    PubMed  PubMed Central  Google Scholar 

  • Lin C, Cai X, Zhang J, Wang W, Sheng Q, Hua H, Zhou X (2018) Role of gut microbiota in the development and treatment of colorectal cancer. Digestion 100:1–7. https://doi.org/10.1159/000494052

    Article  Google Scholar 

  • Liu XJ, Yu R, Zou KF (2019) Probiotic mixture VSL#3 alleviates dextran sulfate sodium-induced colitis in mice by downregulating T follicular helper cells. Curr Med Sci 39(3):371–378. https://doi.org/10.1007/s11596-019-2045-z

    Article  CAS  PubMed  Google Scholar 

  • Lu Y, Chen J, Zheng J, Hu G, Wang J, Huang C, Lou L, Wang X, Zeng Y (2016) Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Sci Rep 6:26337. https://doi.org/10.1038/srep26337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Maldonado Galdeano C, Novotny Nuñez I, Carmuega E, de Moreno de LeBlanc A, Perdigón G (2015) Role of probiotics and functional foods in health: gut immune stimulation by two probiotic strains and a potential probiotic yoghurt. Endocr Metab Immune Disord Drug Targets 15:37–45. https://doi.org/10.2174/1871530314666141216121349

    Article  CAS  PubMed  Google Scholar 

  • Mohania D, Kansal VK, Sagwal R, Shah D (2013) Anticarcinogenic effect of probiotic Dahi and piroxicam on DMH-induced colorectal carcinogenesis in Wistar rats. Am J Cancer Ther Pharmacol 1:1–17

    Google Scholar 

  • Mori G, Rampelli S, Orena BS, Rengucci C, De Maio G, Barbieri G, Passardi A, Casadei Gardini A, Frassineti GL, Gaiarsa S, Albertini AM, Ranzani GN, Calistri D, Pasca MR (2018) Shifts of faecal microbiota during sporadic colorectal carcinogenesis. Sci Rep 8(1):10329. https://doi.org/10.1038/s41598-018-28671-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moura NA, Caetano BF, Sivieri K, Urbano LH, Cabello C, Rodrigues MA, Barbisan LF (2012) Protective effects of yacon (Smallanthus sonchifolius) intake on experimental colon carcinogenesis. Food Chem Toxicol 50:2902–2910. https://doi.org/10.1016/j.fct.2012.05.006

    Article  CAS  PubMed  Google Scholar 

  • Nakamura J, Kubota Y, Miyaoka M, Saitoh T, Mizuno F, Benno Y (2002) Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol Immunol 46:487–490

    CAS  PubMed  Google Scholar 

  • Nakamura Y, Nosaka S, Suzuki M, Nagafuchi S, Takahashi T, Yajima T, Takenouchi-Ohkubo N, Iwase T, Moro I (2004) Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice. Clin Exp Immunol 137(1):52–58

    CAS  PubMed  PubMed Central  Google Scholar 

  • Newell L, Heddle JA (2004) The potent colon carcinogen, 1,2-dimethylhydrazine induced mutations primarily in the colon. Mutat Res 564:1–7

    CAS  PubMed  Google Scholar 

  • Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T (2005) Oral administration of Butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr 135(12):2878–2883

    CAS  PubMed  Google Scholar 

  • Pagès F, Galon J, Dieu-Nosjean MC, Tartour E, Sautès-Fridman C, Fridman WH (2010) Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29:1093–1102

    PubMed  Google Scholar 

  • Park ES, Yoo JM, Yoo HS, Yoon DY, Yun YP, Hong J (2014) IL-32 gamma enhances TNF-alpha-induced cell death in colon cancer. Mol Carcinog 53(Suppl 1):E23–E35

    CAS  PubMed  Google Scholar 

  • Parks DH, Tyson GW, Hugenholtz P, Beiko RG (2014) STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30(21):3123–3124. https://doi.org/10.1093/bioinformatics/btu494

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paula HAA, Martins JFL, Sartori SSR, Castro ASB, Abranches MV, Rafael VC, Ferreira CLLF (2012) The yacon product PBY: Which is the best dose to evaluate the functionality of this new source of prebiotic fructans? Functional Foods Forum Probiotics, Turku

    Google Scholar 

  • Perše M, Cerar A (2011) Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. J Biomed Biotechnol 2011:1–14

    Google Scholar 

  • Prosberg M, Bendtsen F, Vind I, Petersen AM, Gluud LL (2016) The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis. Scand J Gastroenterol:1–9

  • Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39–51

    CAS  PubMed  PubMed Central  Google Scholar 

  • Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr:1939–1951

  • Reiff C, Delday M, Rucklidge G, Reid M, Duncan G, Wohlgemuth S, Hörmannsperger G, Loh G, Blaut M, Collie-Duguid E, Haller D, Kelly D (2009) Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 15(11):1721–1736. https://doi.org/10.1002/ibd.20999

    Article  CAS  PubMed  Google Scholar 

  • Reis SA, Conceição LL, Siqueira NP, Rosa DD, Silva LL, Peluzio MCG (2017) Review of the mechanisms of probiotic actions in the prevention of colorectal cancer. Nutr Res 37:1–19. https://doi.org/10.1016/j.nutres.2016.11.009

    Article  CAS  PubMed  Google Scholar 

  • Roberfroid MB (2005) Introducing inulin-type fructans. Br J Nutr 93:S13–S25

    CAS  PubMed  Google Scholar 

  • Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner JM, Cohen ND, Jergens AE, Suchodolski JS (2014) Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS One 9(4):e94699. https://doi.org/10.1371/journal.pone.0094699

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Russo D, Valentão P, Andrade PB, Fernandez EC, Milella L (2015) Evaluation of antioxidant, antidiabetic and anticholinesterase activities of Smallanthus sonchifolius landraces and correlation with their phytochemical profiles. Int J Mol Sci 16(8):17696–17718. https://doi.org/10.3390/ijms160817696

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saus E, Iraola-Guzmana S, Willisa JR, Brunet-Vegac A, Gabaldon T (2019) Microbiome and colorectal cancer: roles in carcinogenesis and clinical potential. Mol Asp Med 69:93–106. https://doi.org/10.1016/j.mam.2019.05.001

    Article  CAS  Google Scholar 

  • Scheppach W, Weiler F (2004) The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care 7(5):563–567

    PubMed  Google Scholar 

  • Shinde T, Perera AP, Vemuri R, Gondalia SV, Beale DJ, Karpe AV, Shastri S, Basheer W, Southam B, Eri R, Stanley R (2020) Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseases. Eur J Nutr. https://doi.org/10.1007/s00394-020-02200-9

  • Sivieri K, Spinardi-Barbisan ALT, Barbisan LF, Bedani R, Pauly ND, Carlos IZ, Benzatti F, Vendramini RC, Rossi EA (2008) Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male wistar rats. Eur Food Res Technol 228:231–237

    CAS  Google Scholar 

  • Smiricky-Tjardes MR, Grieshop CM, Flickinger EA, Bauer LL, Fahey GC Jr (2003) Dietary galactooligosaccharides affect ileal and total tract nutrient digestibility, ileal and fecal bacterial concentrations, and ileal fermentative characteristics of growing pigs. Anim Sci J 81:2535–2545

    CAS  Google Scholar 

  • Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15(8):1183–1189

    CAS  PubMed  Google Scholar 

  • Son SH, Jeon HL, Yang SJ, Sim MH, Kim YJ, Lee NK, Paik HD (2017) Probiotic lactic acid bacteria isolated from traditional Korean fermented foods based on β-glucosidase activity. 27(1):123–129. https://doi.org/10.1007/s10068-017-0212-1

  • Štofilová J, Szabadosová V, Hrčková G, Salaj R, Bertková I, Hijová E, Strojný L, Bomba A (2015) Co-administration of a probiotic strain Lactobacillus plantarum LS/07 CCM7766 with prebiotic inulin alleviates the intestinal inflammation in rats exposed to N,N-dimethylhydrazine. Int Immunopharmacol 24(2:361–368. https://doi.org/10.1016/j.intimp.2014.12.022

    Article  CAS  Google Scholar 

  • Talero E, Bolivar S, Ávila-Román J, Alcaide A, Fiorucci S, Motilva V (2015) Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by VSL#3. Inflamm Bowel Dis 21:1027–1037. https://doi.org/10.1097/MIB.0000000000000346

    Article  PubMed  Google Scholar 

  • Tandon D, Haque MM, Gote M, Jain M, Bhaduri A, Dubey AK, Mande SS (2019) A prospective randomized, double-blind, placebo-controlled, dose response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora. Sci Rep 9(1):5473

    PubMed  PubMed Central  Google Scholar 

  • Tjalsma H, Boleij A, Marchesi JR, Dutilh BE (2012) A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 10:575–582. https://doi.org/10.1038/nrmicro2819

    Article  CAS  PubMed  Google Scholar 

  • Treu L, Kougias PG, De Diego-Díaz B, Campanaro S, Bassani I, Fernández-Rodríguez J, Angelidaki I (2018) Two-year microbial adaptation during hydrogen-mediated biogas upgrading process in a serial reactor configuration. Bioresour Technol 264:140–147. https://doi.org/10.1016/j.biortech.2018.05.070

    Article  CAS  PubMed  Google Scholar 

  • Tryland I, Fiksdal L (1998) Enzyme characteristics of beta-D-galactosidase- and beta-D-glucuronidase-positive bacteria and their interference in rapid methods for detection of waterborne coliforms and Escherichia coli. Appl Environ Microbiol 64:1018–1023

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tsukamoto T, Kozaki K, Nishikawa Y, Yamamoto M, Fukami H, Inoue M, Wakabayashi K, Tatematsu M (1999) Development and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Jpn J Cancer Res 90:720–725

    CAS  PubMed  PubMed Central  Google Scholar 

  • Uccello M, Malaguarnera G, Basile F, D’agata V, Malaguarnera M, Bertino G, Vacante M, Drago F, Biondi A (2012) Potential role of probiotics on colorectal cancer prevention. BMC Surg 12(suppl 1):S35

    PubMed  PubMed Central  Google Scholar 

  • Uchiyama K, Sakiyama T, Hasebe T, Musch MW, Miyoshi H, Nakagawa Y, He TC, Lichtenstein L, Naito Y, Itoh Y, Yoshikawa T, Jabri B, Stappenbeck T, Chang EB (2016) Butyrate and bioactive proteolytic form of Wnt-5a regulate colonic epithelial proliferation and spatial development. Sci Rep 6:32094. https://doi.org/10.1038/srep32094

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB, Jobin C (2011) Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis 17:289–297

    PubMed  Google Scholar 

  • Velez E, Castillo N, Mesón O, Grau A, Bonet MEB, Perdigón G (2013) Study of the effect exerted by fructo-oligosaccharides from yacon (Smallanthus sonchifolius) root flour in an intestinal infection model with Salmonella Typhimurium. Br J Nutr 109:1971–1979. https://doi.org/10.1017/S0007114512004230

    Article  CAS  PubMed  Google Scholar 

  • Verma A, Shukla G (2013) Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats. Nutr Cancer 65:84–91. https://doi.org/10.1080/01635581.2013

    Article  PubMed  Google Scholar 

  • Verma A, Shukla G (2014) Synbiotic (Lactobacillus rhamnosus + Lactobacillus acidophilus + inulin) attenuates oxidative stress and colonic damage in 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis in Sprague-Dawley rats: a long-term study. Eur J Cancer Prev 23(6):550–559

    CAS  PubMed  Google Scholar 

  • Villarini M, Caldini G, Moretti M, Trotta F, Pasquini R, Cenci G (2008) Modulatory activity of a Lactobacillus casei strain on 1,2-dimethylhydrazine-inducedgenotoxicity in rats. Environ Mol Mutagen 49(3):192–199. https://doi.org/10.1002/em.20367

    Article  CAS  PubMed  Google Scholar 

  • Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L (2011) Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6:320–329. https://doi.org/10.1038/ismej.2011.109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D, Mallitt KA, Hu Y, Irahara N, Ogino S, Leggett BA, Young GP (2009) A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90:578–586

    CAS  PubMed  Google Scholar 

  • Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15:1016–1022. https://doi.org/10.1038/nm.2015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, Chen Y, Yang F, Lu N, Wang Z, Luan C, Liu Y, Wang B, Xiang C, Wang Y, Zhao F, Gao FG, Wang S, Li L, Zhang H, Zhu B (2013) Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 66:462–470. https://doi.org/10.1007/s00248-013-0245-9

    Article  CAS  PubMed  Google Scholar 

  • Yu LCH (2018) Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J Biomed Sci 25:79. https://doi.org/10.1186/s12929-018-0483-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zavisic G, Petricevic S, Radulovic Z, Begovic J, Golic N, Topisirovic L, Strahinic I (2012) Probiotic features of two oral Lactobacillus isolates. Braz J Microbiol 43:418–428. https://doi.org/10.1590/S1517-838220120001000050

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu Q, Gao R, Wu W, Qin H (2013) The role of gut microbiota in the pathogenesis of colorectal cancer. Tumor Biol 34:1285–1300

    Google Scholar 

Download references

Acknowledgments

Our work was supported by the National Council of Technological and Scientific Development (CNPq), Coordination for the Improvement of Higher Education Personnel (CAPES), and Foundation for the Support to the Researches in Minas Gerais (Fapemig).

Author information

Authors and Affiliations

Authors

Contributions

BCSC, MCGP, and CLLFF conceived and designed the research. BCSC, VSD, and LSF conducted the experiments. AG, VC, VMG, SOP, and MCGP contributed new reagents or analytical tools. BCSC, VSD, and LSF analyzed data. BCSC wrote the manuscript. All authors read and approved the manuscript.

Corresponding author

Correspondence to Bruna Cristina dos Santos Cruz.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All experimental protocols were approved by the Ethics Committee in Animal Experimentation of the Federal University of Viçosa (n° 08/2017, date of approval: May 09, 2017), under the guidelines of the European Community (Directive 2010/63/EU).

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(PDF 1153 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

dos Santos Cruz, B.C., da Silva Duarte, V., Giacomini, A. et al. Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model. Appl Microbiol Biotechnol 104, 8837–8857 (2020). https://doi.org/10.1007/s00253-020-10863-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-020-10863-x

Keywords

Navigation